Intrinsiqs

Is Vir Biotechnology, Inc. overvalued?

Vir Biotechnology, Inc. (VIR) — key valuation metrics and fundamentals.

No verdict
Price
$10.66
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.80B
Dividend yield
0.0%
Return on equity
-30.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VIR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.